Valbiotis SA (EPA:ALVAL)

Valbiotis Statistics

Total Valuation

Valbiotis has a market cap or net worth of EUR 23.66 million. The enterprise value is 15.77 million.

Market Cap	23.66M
Enterprise Value	15.77M

Important Dates

The last earnings date was Tuesday, March 3, 2026.

Earnings Date	Mar 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Valbiotis has 23.66 million shares outstanding. The number of shares has increased by 11.98% in one year.

Current Share Class	23.66M
Shares Outstanding	23.66M
Shares Change (YoY)	+11.98%
Shares Change (QoQ)	+0.61%
Owned by Insiders (%)	3.01%
Owned by Institutions (%)	3.28%
Float	22.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.14
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.68
EV / Sales	17.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	3.17%
Revenue Per Employee	20,568
Profits Per Employee	-214,023
Employee Count	44
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Valbiotis has paid 2,000 in taxes.

Income Tax	2,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.89% in the last 52 weeks. The beta is -0.20, so Valbiotis's price volatility has been lower than the market average.

Beta (5Y)	-0.20
52-Week Price Change	-6.89%
50-Day Moving Average	0.93
200-Day Moving Average	0.83
Relative Strength Index (RSI)	49.95
Average Volume (20 Days)	176,026

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Valbiotis had revenue of EUR 905,000 and -9.42 million in losses.

Revenue	905,000
Gross Profit	-1.17M
Operating Income	-9.49M
Pretax Income	-9.42M
Net Income	-9.42M
EBITDA	-9.38M
EBIT	-9.49M
Earnings Per Share (EPS)	n/a

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cash Flow

Operating Cash Flow	-8.04M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	-128.84%
Operating Margin	-1,049.06%
Pretax Margin	-1,040.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Valbiotis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.98%
Shareholder Yield	-11.98%
Earnings Yield	-39.81%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3